Medication Adherence Technology
Compliance and Ethics Incident Report
41 Avada Avenue, Florida, 98765
Andrew Brynes joined Altruix in January of 2024 as Chief Financial Officer, bringing twenty-five years of broad strategic, financial and operational leadership to the company. In his role, Andy is responsible for all aspects of financial management for the enterprise, including financial planning, forecasting and reporting, business analysis, revenue cycle management, treasury, tax compliance, banking and investor relations.
Prior to joining Altruix, Andy served as the Chief Financial Officer for CarelonRx, the $30Bn pharmacy benefit management (PBM) division of Elevance Health, Inc. (formerly “Anthem”), where he helped to lead the organization through a period of rapid growth and expansion. Prior to that, Andy served as Managing Director of Loeb Enterprises, a NYC-based private investment firm with a portfolio of over thirty rapidly growing companies spanning healthcare, technology, and consumer-facing sectors. Earlier in his career, Andy led Strategy and Corporate Development for Blue Cross Blue Shield of North Carolina, where he was responsible for enterprise strategy, corporate development, innovation and building a portfolio of healthcare services and technology companies to drive earnings growth and diversification.
Andy began his career as a CPA with the public accounting firm KPMG. He earned a Bachelor of Science in Accounting from the University of Rhode Island and a Master’s degree in Business Administration from Duke University. Andy and his family reside in Baltimore, MD, where most recently he served on the Board of the Maryland Chapter of the March of Dimes. He enjoys skiing and tennis and is an avid college basketball fan.
Frank Meaney serves as Altruix’s Senior Vice President of Finance and oversees the Company’s finance, accounting and revenue cycle management functions. He brings over 35 years of corporate finance and accounting experience in the healthcare and pharmacy industries.
Prior to Altruix, Frank served as the chief financial officer of Braven Health, a joint venture Medicare Advantage Health Plan backed by 2 of the largest health systems in NJ in partnership with Horizon BCBS of NJ. Frank also served as the CFO for Neighborhood Health Plan of RI, a multi-line health plan insurer with Medicare, Medicaid and Commercial lines of business with $1.6B in annual revenue. Frank has also served in senior finance management positions at Health New England, Cigna, Aetna and Anthem.
Frank earned a Bachelor of Science in Business Administration from Central Connecticut State University and is a CPA.
Yeardley Green has been part of the Altruix team since 2010. His leadership helped Terrapin Pharmacy, now Altruix, offer innovative pharmacy service models designed to optimize both patient outcomes and provider workflows. In 2012, Yeardley worked with his team to patent Altruix’s groundbreaking medication adherence technology, Medherent. In his current role as EVP of Sales and Business Development, Yeardley leads a team that is responsible for growth in both the Long-Term Care and Specialty Pharmacy business segments.
Prior to Altruix, he was responsible for selling large scale IT infrastructure, IT services, and software for Systems Alliance Corp. Before Systems Alliance, he worked at Under Armour where he managed the marketing efforts at key accounts like Dick’s Sporting Goods and the Sports Authority.
Yeardley has been with Altruix for 13 years because he is deeply connected to the mission of providing life changing care to underserved people with complex conditions. He is a proud father of two and spends his free time on his small farm north of Baltimore. Yeardley is a graduate of the Sewanee, The University of the South where he earned a B.A. in Economic Development, during which time he spent a full year in Beijing learning Mandarin and studying emerging markets.
A leader with over 36 years in healthcare services and technology, Tim Liebmann is responsible for optimizing and maintaining best-in-class operations across the Altruix pharmacy portfolio.
Immediately prior to joining Altruix, Tim was the Chief Commercial Officer of FliptRx. Tim also served as Chief Operating Officer of Fred’s Pharmacy where he was responsible for putting together the divestiture of Rite Aid stores to Fred’s from the Walgreens/Rite Aid merger announced on December, 2016, and the process via the Federal Trade Commission for approval of the transaction.
Prior to Fred’s, Tim was the founder, Chairman and CEO of SUNRx, one of the largest 340B Administrators in the country. From a cold start, he built the leading technology that allowed for the massive growth of 340B in the United States. Tim sold SUNRx to MedImpact in 2012.
Tim graduated from LaSalle University in Philadelphia, PA, with a Bachelor of Science in Accounting.
Eric Elliott joined Altruix as chief executive officer in 2022. In this role, Eric drives efforts to deliver personalized behavioral health pharmacy services. Eric is leveraging the full power of the organization’s behavioral health expertise, growing physical presence, data, and innovative technology to unleash a pharmacy platform that improves health outcomes and access for vulnerable populations. In addition to his role and serving on the board at Altruix, Eric is currently Lead Independent Director at Welldyne, a full-service pharmacy benefit manager servicing membership through health plan and employer direct agreements. Welldyne is a portfolio company of The Carlyle Group. He also serves when needed as Senior Healthcare Advisor at Warburg Pincus since 2018. Eric was the Board Chair of Voluntis S.A., a digital therapeutics company focused on alternative and combination therapies in several disease states from 2016 until its transaction with the Aptar Group in 2021.
During his time as Chair at Voluntis, the company grew exponentially, went public on the EuroNext exchange, and transacted successfully expanding Aptar’s focus in digital therapeutics and drug administration alternatives. Prior to these roles, Eric led three organizations operating in the pharmacy benefit management industry. In his most recent operating role, he was Prime Therapeutics’ President and Chief Executive Officer (April 2010-April 2015). With approximately $20 billion in annualized drug spend under management at the time of his departure, Prime was the fourth largest pharmacy benefit manager in the United States. Under his leadership, Prime was recognized locally and nationally by prominent publications and organizations for its employee engagement, healthy workplace, highest quality and care of service for members, and business growth. During Eric’s tenure, Prime Therapeutics more than doubled in size and accelerated the value created by the organization more than fourfold.
Before his time at Prime Therapeutics, Eric held the role of president at Cigna Pharmacy Management and president of Aetna Pharmacy Management prior to his time at Cigna. He received his bachelor’s degree in management and finance, and a Master of Business Administration from Temple University in Philadelphia. He served for many years on the board of directors at Prime Therapeutics, the Pharmaceutical Care Management Association, Main Street America (a super-regional property and casualty insurance provider), Voluntis S.A., and the Twin Cities American Heart Association.
Renee Treberg joins Altruix with more than 30 years experience in healthcare, operations, and compliance. In her role as SVP, Support Services and Chief Compliance Officer, Renee ensures the Altruix team has the tools, policies, and compliance processes needed to improve the lives of people through exceptional, caring pharmacy services.
Prior to joining Terrapin Pharmacy, Renee served as Prime Therapeutic’s Chief Compliance Officer and government programs compliance officer. In this role, Renee led compliance and ethics programs for Prime Therapeutics, LLC, Medicare, Medicaid, and Commercial work. In addition, Renee had executive functional leadership over Prime’s licensing, accreditation, external audit, privacy and FWA activities.
Prior to her time at Prime Therapeutics, she served as the chief operations and compliance officer for a multi-site mental health clinic. Earlier in her career, Renee worked as the director of operations and compliance for a behavioral health benefit management company. Renee has a master of business administration from the University of St Thomas and is a certified compliance and ethics professional.
Renee is inspired by the mission to help advance the health and well-being of individuals. She is drawn to work and organizations that allow for strategic thinking, innovation, and creative problem solving. She enjoys opportunities that allow for designing and building programs, services or processes that provide creative solutions to the health needs of others. She is driven by a serving compassionately and living generously.
Thom Stambaugh joined Altruix to develop partnerships with key healthcare stakeholders, improve patient outcomes and lead the clinical direction for Altruix’s innovative pharmacy platform. Thom brings to Altruix a passion for helping people on medications achieve the best outcomes for a fair price.
Prior to Altruix, Thom was the Chief Pharmacy Officer at Flipt, a high tech/high touch pharmacy benefit management company with a transparent and pass through business model. At Flipt, Thom led clinical, specialty, and benefit strategy. Thom also built Flipt’s sales team from the ground up, and partnered to win their largest clients, including Novartis, J&J and Medtronic.
Previously, Thom spent 23 years at Cigna, serving a wide range of roles, including Chief Pharmacy Officer, Vice President of Specialty Pharmacy, and Vice President of Value Based Partnerships. Thom’s accomplishments include developing solutions at Cigna to help people with complex psychiatric conditions and controlled substance abuse get expert clinical care from behavioral specialists. In addition, Thom created value-based contracts with physician groups, pharmacies, and pharmaceutical manufacturers that incentivized each stakeholder to improve clinical outcomes and cost of care for patients on medications.
Christy Rosado joined Altruix in 2022 as President, Long-Term Care Pharmacy & Chief Marketing Officer. In her role, Christy is responsible for oversight of the long-term care pharmacy operation and market positioning. She has over 25 years of experience in the pharmacy industry, with the past 12 years focused on behavioral health pharmacy.
Christy began her career in 1994 as store manager for CVS Pharmacy. From 1998 to 2010, she worked for Rite Aid Pharmacy, holding several positions including Training Store Manager, Regional Trainer, Front End Supervisor, Regional Pharmacy Recruiter, District Manager and Pharmacy District Manager.
Her most recent position prior to Altruix was as Senior Vice President of Sales for Genoa Healthcare, a United Healthcare – OptumRx company. Before her departure from Genoa, she led growth for the organization from 40 pharmacies to over 600 locations.
Christy’s strong leadership skills have propelled her through a successful career, but it’s her passion for connecting with people and delivering on Altruix’s mission that truly makes a lasting impact. Her own personal experience has resulted in her love for the community Altruix serves. In the words of her favorite Bryan Adam’s song, “Everybody needs somebody.”
Christy graduated from Danville Community College in 1991, majoring in Marketing.
John Ginzler serves as Altruix’s Chief Financial Officer and oversees the Company’s finance, accounting and revenue cycle management functions. He brings over 30 years of corporate finance and accounting experience in the healthcare, pharmacy and biotechnology industries.
Prior to Altruix, John served as the chief financial officer of Soleo Health, a national provider of specialty infusion drug therapies. John also served in senior finance management positions at Opexa Therapeutics, Power3 Medical Products and Critical Care Systems.
John earned a Bachelor of Science in Business Administration from Northeastern University and an MBA from Babson College.
With over 20 years of pharmacy experience, Greg Ganse leads the direction for strategic partnerships, mergers & acquisitions, business integration and enterprise strategy at Altruix. Greg was formerly the President, CEO and owner of Ganse Apothecary, an independent family pharmacy, which was acquired by Altruix in 2022.
Prior to leading Ganse Apothecary, he spent time working for Teva Pharmaceuticals and Covidien Healthcare. Greg’s passion for organizational development and serving a population that is underfunded and underserved is what led to the success of his pharmacy.
Greg graduated from Muhlenberg College in 2001 with a BA in Entrepreneurial Studies and German Language and Literature.